Susquehanna Maintains Positive on NOV, Raises Price Target to $22

Benzinga Newsdesk www.benzinga.com Positive 91.2%

Neg 0% Neu 0% Pos 91.2%

Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the price target from $21 to $22.